Scarica l'app Stockscreener
2.99
1.64%
-0.06
Precedente Chiudi:
$3.05
Aprire:
$3.0951
Volume 24 ore:
24,134
Relative Volume:
0.06
Capitalizzazione di mercato:
$9.13M
Reddito:
-
Utile/perdita netta:
$2.81M
Rapporto P/E:
-0.2084
EPS:
-14.3497
Flusso di cassa netto:
$7.14M
1 W Prestazione:
-5.66%
1M Prestazione:
-0.99%
6M Prestazione:
-21.67%
1 anno Prestazione:
-36.03%
Intervallo 1D:
$2.9901
$3.10
Intervallo di 1 settimana:
$2.96
$3.2328
Portata 52W:
$2.51
$4.80
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Nome
Kiora Pharmaceuticals Inc
Settore
Industria
Telefono
781-788-8869
Indirizzo
332 ENCINITAS BOULEVARD, ENCINITAS
Confronta KPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
3.00 | 9.47M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.94 | 122.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.75 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
592.45 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.53 | 31.91B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Borsa (KPRX) Ultime notizie
What analysts say about Kiora Pharmaceuticals Inc. stockPhenomenal trading returns - PrintWeekIndia
Kiora Pharmaceuticals Secures US Patent for KIO-104 - Ophthalmology Times
What drives Kiora Pharmaceuticals Inc. stock priceConsistent high-performance stocks - Autocar Professional
Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional
KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus
Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals receives patent for ocular disease treatment By Investing.com - Investing.com Canada
Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com Australia
Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan
Is Kiora Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN
Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com
How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
What makes Kiora Pharmaceuticals Inc. stock price move sharplyPredictable Return Stock Picks - Newser
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World
Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times
kiora pharmaceuticals reports results of annual shareholder meeting By Investing.com - Investing.com South Africa
kiora pharmaceuticals reports results of annual shareholder meeting - Investing.com
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors - TipRanks
Oil Prices Climb While US Equity Futures Stutter - Finimize
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard SurgeMore Stocks Inside! - openPR.com
Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside! - FinancialContent
Markets | American Financial Group, Inc. - FinancialContent
Kiora Pharmaceuticals inks potential $110 million deal with Senju By Investing.com - Investing.com South Africa
ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize
Sector Update: Health Care - marketscreener.com
Kiora Pharmaceuticals Inc Azioni (KPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kiora Pharmaceuticals Inc Azioni (KPRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Shapiro Aron | Director |
Sep 10 '24 |
Buy |
3.60 |
3,000 |
10,800 |
3,000 |
| Walters-Hoffert Lisa | Director |
Aug 19 '24 |
Buy |
3.86 |
1,250 |
4,825 |
1,250 |
| TYLE PRAVEEN | Director |
Aug 19 '24 |
Buy |
3.96 |
5,000 |
19,800 |
5,014 |
| Tosca Melissa | CFO |
Aug 14 '24 |
Buy |
3.21 |
2,000 |
6,420 |
13,599 |
1.74%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):